×

Error

There was a problem loading image LEKETlogo11870681_940029516055704_2554505469251269831_n.jpg
×

Message

fsockopen(): unable to connect to ssl://query.yahooapis.com:443 (php_network_getaddresses: getaddrinfo failed: Name or service not known)

We are pleased to announce the launch of a new fellowship scheme as part of the BIRAX Regenerative Medicine Initiative. The initiative is a five year programme intended to support research collaborations between the UK and Israel in the field of regenerative medicine. 

 

The fellowship scheme will support visits by researchers to laboratories for up to six months. More information is available on the BIRAX Regenerative Medicine Initiative website.

 

 

The fellowship programme follows the awarding of grants for seven new large scale collaborationsbetween scientists in the UK and Israel.

  

Increasing collaboration between academics and institutions is a central part of the work of the British Embassy and the British Council. The BIRAX programme is one of the most successful ways of doing this.

  • In January, BIRAX Regenerative Medicine Initiative award recipients from the UK joined their Israeli counterparts at a two day scientific workshop, hosted by the University of Haifa. Research partners shared details of their joint projects and discussed possible synergies.  A selection of photos from the workshop
     
  • The second UK-Israel Regenerative Medicine Conference is scheduled for 13-14 November 2013, where the second Call for Proposals will be announced. We will bring together leading academics from Israel and the UK. The conference will be generously hosted by the Technion Institute of Technology.  Here is a reminder from the first conference at Ben-Gurion University of the Negev: 

 The BIRAX regenerative medicine programme would not have been possible without the invaluable support of a number of partner organisations and individuals, notably the Bonita Trust, Lord Fink, the Kahn Foundation, the Pears Foundation, the Israeli Ministry of Science and Technology, the Rosetrees Trust, the Maurice and Vivienne Wohl Philanthropic Foundation, the MRC (Medical Research Council), the UJIA, the Wolfson Family Charity Trust, and Yad Hanadiv. We are extremely grateful for their generosity and cooperation.